EWTX   $35.51  1.37% Market Closed After Close 35.42 -0.25%

Edgewise Therapeutics Inc
Total Cash 511.75M
totalCashPerShare 5.457
EBITDA -134.29M
Total Debt 4.99M
quickRatio 29.795
currentRatio 30.242
Total Revenue
debtToEquity 0.977
Revenue/Share
ROA -0.19740999
ROE -0.28197
grossProfits
freeCashflow -62.31M
operatingCashflow -103.58M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.59B
forwardPE -18.73262
floatShares 53.52M
sharesOutstanding 93.77M
sharesShort 9.34M
sharesShortPriorMonth 7.78M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.12%
Short Ratio help_outline 5.47%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue 5.451
Price To Book help_outline 6.43
earningsQuarterlyGrowth
netIncomeToCommon -115.88M
trailingEps -1.53%
forwardEps -1.87%
enterpriseToEbitda -19.26
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.37 3Q 2024
institutionsCount 214
lastUpdated Oct. 16, 2024, 11:56 p.m.